Skip to main content

Analysts Offer Insights on Consumer Cyclical Companies: Rollins (ROL) and DR Horton (DHI)

Tipranks - Thu Jan 22, 6:08AM CST

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Rollins (ROLResearch Report) and DR Horton (DHIResearch Report).

Claim 50% Off TipRanks Premium

Rollins (ROL)

RBC Capital analyst Ashish Sabadra maintained a Buy rating on Rollins yesterday and set a price target of $70.00. The company’s shares closed last Tuesday at $63.11.

According to TipRanks.com, Sabadra is a 5-star analyst with an average return of 6.3% and a 62.8% success rate. Sabadra covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Cboe Global Markets, and Factset Research. ;'>

Currently, the analyst consensus on Rollins is a Strong Buy with an average price target of $67.91, representing an 8.7% upside. In a report issued on January 14, Wells Fargo also maintained a Buy rating on the stock with a $68.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

DR Horton (DHI)

RBC Capital analyst Michael Dahl maintained a Sell rating on DR Horton yesterday and set a price target of $117.00. The company’s shares closed last Tuesday at $153.19.

According to TipRanks.com, Dahl is a 5-star analyst with an average return of 9.6% and a 60.5% success rate. Dahl covers the Industrial Goods sector, focusing on stocks such as Fortune Brands Innovations, SiteOne Landscape Supply, and Builders Firstsource. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for DR Horton with a $160.45 average price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.